Many of the same factors have propelled big banks’ strong performance: a solid economic backdrop with low unemployment, corporate clients’ appetite for executing big deals, and lots of trading activity.
Actualités
Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.
We recently published Ray Dalio Stock Portfolio: 10 Best Stocks to Buy. Advanced Micro Devices, Inc. (NASDAQ:AMD) is one of Ray Dalio’s best stocks to buy. On July 6, Advanced Micro Devices, Inc. (NASDAQ:AMD) shares rose 6.6% to $551.98 after Goldman Sachs raised its price target to $640 from $450. The firm reiterated a Buy rating. […]
The antitrust lawsuit could delay the merger after federal approval and before Europe's July 22 decision.
Chipotle Mexican Grill (NYSE:CMG), a U.S. restaurant chain offering customizable Mexican-inspired food, is expanding into Mexico with its first location scheduled to open Thursday in the Monterrey metropolitan area. The company is entering the market in partnership with Alsea, a Latin American restaurant operator that manages brands including Starbucks across the region. Chipotle plans to open additional restaurants in Nuevo Leon later this year before expanding into Mexico City in 2027, suggesting the company is taking a phased approach to building its presence in the country.
Micron Technology (MU) just took a financial stake in a wafer supplier that most investors have never heard of. On paper, it reads like a routine line item inside a much larger spending announcement. Wedbush Securities says it’s something else: an early signal that the AI memory boom is about to ...
Gedatolisib, in-licensed from Pfizer in 2021, is Celcuity’s sole late-stage asset.
There’s no sugarcoating it; getting laid off is awful. But if you've been following the news, it feels like tech workers are being laid off left and right. Here’s what one Reddit user, who was recently laid off from an account executive role at a tech company, had to say on the r/Layoffs subreddit: ...
Shares of the corporate stalwart plunged 25% as AI purchases crowd out traditional tech spending in many companies’ budgets.
Lenders’ results contrast with measures that show the highest credit card delinquency rates in 15 years.
(Updates with index/price moves, macroeconomic data, and geopolitical news from the first paragraph.
Alcoa said it and the governments of Australia, Japan and the U.S. have reached a final investment decision to build a gallium production plant at the company’s Wagerup alumina refinery in Western Australia.
IBM stock suffered its worst day ever on Tuesday after the company’s preliminary second-quarter earnings missed analysts’ targets. In a letter to shareholders, CEO Arvind Krishna explained the shortfall was largely driven by the company’s infrastructure business. “What played out was worse than our expectations,” Krishna wrote.
Second-quarter earnings and June consumer inflation data offset continuing uncertainty about the Strait of Hormuz.
Find insight on Bank of America, Goldman Sachs, Citigroup and more in the latest Market Talks covering financial services.
Goldman Sachs reports record $20.3 billion in revenue and a 25% dividend increase, while navigating market volatility and regulatory challenges.
Wells Fargo & Co (WFC) reports a 25% increase in earnings per share and 9% revenue growth, while navigating expense pressures and market uncertainties.
JPMorgan Chase & Co (JPM) reports robust financial performance with a net income of $16.9 billion and a 15% revenue increase, despite challenges from rising expenses and credit costs.
Bank of America Corp (BAC) reports strong financial performance with significant revenue and net income growth, while navigating economic challenges and leveraging AI for operational efficiency.
Netflix is set to release quarterly results after markets close Thursday, with a big move from the streamer’s stock expected to follow.
A hectic day in markets lifted stocks Tuesday, thanks to booming bank profits and an unexpectedly upbeat inflation report. All major U.S. indexes ended the day in the green, despite a historic fall from grace for one member of the Dow industrials. The Dow industrials edged less than 0.1% higher, weighed down by tumbling shares of International Business Machines.

Chinese large language model (LLM) developer DeepSeek is reportedly preparing for an IPO later this year or in 2027. Yahoo Finance Technology Editor Dan Howley outlines what we know so far.
U.S. stocks rose as blockbuster bank earnings and a cooler-than-expected inflation report boosted sentiment, while a profit warning from IBM weighed on the Dow Industrials and dragged software stocks lower.
(Bloomberg) -- OpenAI's much-anticipated push into consumer devices is slated to begin with a mobile, screen-free smart speaker designed to be a new type of home computer for the AI era, according to people familiar with the matter.Most Read from BloombergUS Hits Iran With Strikes, Blockade as Trump Plans Hormuz ChargeTrump Shelves 20% Fee for Hormuz Cargo After Gulf PressureA Cocaine Bust in Spain Leads All the Way to Wall StreetUS CPI Falls for the First Time Since 2020, Core Gauge Flat'We Fal
(Bloomberg) -- OpenAI’s much-anticipated push into consumer devices is slated to begin with a mobile, screen-free smart speaker designed to be a new type of home computer for the AI era, according to people familiar with the matter.Most Read from BloombergUS Hits Iran With Strikes, Blockade as Trump Plans Hormuz ChargeTrump Shelves 20% Fee for Hormuz Cargo After Gulf PressureA Cocaine Bust in Spain Leads All the Way to Wall StreetUS CPI Falls for the First Time Since 2020, Core Gauge Flat‘We Fal
Moby summary of Citigroup Inc.'s Q2 2026 earnings call
Moby summary of Wells Fargo & Company's Q2 2026 earnings call
The Federal Trade Commission announced a settlement with CVS Health’s pharmacy benefit manager business on Tuesday, the agency’s second major agreement this year with drug industry middlemen. Pharmacy-benefit managers, or PBMs, play a key role in negotiating with drug companies and selecting which prescription drugs will be covered by an insurance plan. In litigation filed in 2024 during the Biden administration, the commission alleged that rebates and fees collected by major PBMs from drug manufacturers artificially inflated the price of insulin.